- Home
- TRLV vs IMCR Comparison
TRLV vs IMCR Comparison
Compare TRLV & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRLV | IMCR |
|---|---|---|
| Founded | N/A | 2008 |
| Country | | United Kingdom |
| Employees | N/A | 524 |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TRLV | IMCR |
|---|---|---|
| Price | $12.31 | $30.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $66.33 |
| AVG Volume (30 Days) | ★ 1.9M | 329.5K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.58 | ★ 30.39 |
| EPS | N/A | ★ 0.23 |
| Revenue | ★ $1,181,180,000.00 | $249,428,000.00 |
| Revenue This Year | N/A | $14.57 |
| Revenue Next Year | N/A | $8.21 |
| P/E Ratio | ★ N/A | $133.39 |
| Revenue Growth | N/A | ★ 43.05 |
| 52 Week Low | $7.82 | $27.56 |
| 52 Week High | $12.93 | $40.71 |
Technical Indicators
Market Signals| Indicator | TRLV | IMCR |
|---|---|---|
| Relative Strength Index (RSI) | 62.76 | 29.54 |
| Support Level | $10.71 | $30.47 |
| Resistance Level | $12.76 | $31.56 |
| Average True Range (ATR) | 0.77 | 1.23 |
| MACD | -0.01 | -0.31 |
| Stochastic Oscillator | 75.68 | 7.72 |
Price Performance
Historical ComparisonAbout TRLV Trulieve Cannabis Corp. Subordinate Voting Shares
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.